Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

The following table summarizes stock option activity during the three months ended March 31, 2025:


	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value
	(in thousands)			(in years)	(in thousands)
Outstanding at December 31, 2024	2,364	$	8.60	4.3	$	7,592
Granted	—	—
Exercised	(168)	2.43
Cancelled/forfeited	(212)	3.96
Outstanding at March 31, 2025	1,984	9.62		4.6	$	2,146
Vested and exercisable at March 31, 2025	1,608	8.01		3.7	$	2,146

Schedule of RSU, PSU, MPSUs Activity

The following table summarizes RSU activity during the three months ended March 31, 2025:


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Unvested RSUs as of December 31, 2024	11,982	$	13.06
Granted	3,048	7.24
Vested	(2,347)	12.42
Cancelled/forfeited	(548)	13.66
Unvested RSUs as of March 31, 2025	12,135	$	11.69


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Nonvested PSUs as of December 31, 2024	1,089	$	13.21
Granted	1,151	6.82
Vested	(85)	14.56
Cancelled/forfeited	(771)	12.69
Nonvested PSUs as of March 31, 2025	1,384	$	8.11


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Nonvested MPSUs as of December 31, 2024	1,313	$	6.45
Granted	—	—
Vested	—	—
Cancelled/forfeited	—	—
Nonvested MPSUs as of March 31, 2025	1,313	$	6.45


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Nonvested rTSR PSUs as of December 31, 2024	—	$	—
Granted	272	14.15
Vested	—	—
Cancelled/forfeited	—	—
Nonvested rTSR PSUs as of March 31, 2025	272	$	14.15

Schedule of Stock-Based Compensation Expense

The following table summarizes the components of total stock-based compensation expense included in the accompanying condensed consolidated statements of operations:


	Three months ended March 31,
	2025		2024
	(in thousands)
Cost of revenue	$	1,939	$	2,779
Research and development	8,893		10,323
Sales and marketing	6,693		7,843
General and administrative	8,057		10,876
Total stock-based compensation expense	$	25,582	$	31,821